论文部分内容阅读
肿瘤坏死因子在引发炎症反应中起重要的介导作用,其抑制剂如英夫利昔单抗、阿达木单抗、依那西普等被相继批准用于慢性免疫性疾病如风湿性关节炎的治疗。《新型抗风湿类药物戈利木单抗注射剂》一文从作用机制、药动学研究、临床试验、安全性评价等对戈利木单抗注射剂进行了详细论述,为治疗慢性关节炎症疾病及激素依赖的溃疡性结肠炎提供新的药物选择。药物经济学是旨在优化配置和高效利用药物资源的新兴学科,药物经济学评价所需的数据主要通过前
Tumor necrosis factor plays an important mediating role in triggering inflammatory reactions. Inhibitors such as infliximab, adalimumab, etanercept and the like have been approved for chronic immune diseases such as rheumatoid arthritis treatment. The new anti-rheumatic drugs golimumab injections "from the mechanism of action, pharmacokinetic studies, clinical trials, safety evaluation of Golimumab injections were discussed in detail for the treatment of chronic joint inflammatory diseases and hormones Dependent ulcerative colitis offers new drug options. Pharmacoeconomics is an emerging discipline that aims to optimize the allocation and efficient use of pharmaceutical resources. The data required for pharmacoeconomic evaluation mainly pass through